Up to Date News

Independent Studies and Research Summaries
 

New Research in Auto-Immune and Inflammatory Conditions

Documented Case Observations: Crohn's-Disease Remission

Histologically verified remission reported by independent medical centres in South Africa and Australia.

Crohn's-Disease Research Programme
Ulcerative-Colitis Research Programme
Systemic Lupus Erythematosus (SLE) Research Programme
 

Patient Experiences and Global Case Reports
Participant experiences documented under independent medical observation.
 

Preliminary Findings
 

Washington State University Research Reference
 

London (St George's Hospital) Independent Study
 

CFIDS Protocol Contacts Worldwide
 

Independent Professional Commentaries
 

Media Coverage
 

Media Coverage
 

German Reference Publication - Dr Nebojsa Petrovic MD
 

U.S. FDA Compliance Notice (2008-2019)
Documentation of product and facility compliance submissions.
 

Public Figures and International Collaborators
 

  FAQ's
 
FAQ - About the Programme

1. What does Dr Nash Petrovic's programme contain?

It is a formulation of over 200 synergistic micro-antioxidant compounds that help support healthy immune and inflammatory responses, while repairing oxidative cell damage. All ingredients are in capsule or tablet form and easy to swallow.

2. Does the programme contain any scheduled drugs or toxic ingredients?

No. The CFIDS Protocol is natural and non-toxic. It contains no scheduled substances and can be used under a physician's supervision.
Professor Dr Kilroe-Smith, former Director of the South African National Institute for Toxicology and Occupational Health, reviewed the formulation and described it as:

"Completely natural, non-toxic, without adverse effects, and safe for human use."

The Petrovic CFIDS Health Center is registered with the U.S. FDA for safety compliance.

Our production facility was registered with the U.S. FDA for safety oversight under the Public Health Security and Bioterrorism Act.

This registration does not imply FDA evaluation or approval of therapeutic claims.

3. What is the overall success rate of the procedure?

Independent studies and long-term patient outcomes show consistently positive results for individuals meeting CFIDS diagnostic criteria.

4. What is the relapse rate after completing the programme?

Follow-ups since 1994 indicate a very low relapse rate, especially among patients who continue with maintenance supplementation and regular check-ups.

5. Are relapses possible?

Temporary setbacks (such as infections or stress) may occur but full relapses are extremely rare.


FAQ - During the Programme

1. How long does the programme last?

The CFIDS Protocol has three phases - intensive, follow-up, and maintenance.

Average duration: 6-9 months; longer for complex cases.


2. Do I need a special diet?

No strict diet required. Just reduce refined sugar, white flour, and red meat.

3. Can I smoke during the programme?

Smoking may slow improvement but will not prevent recovery.

4. Do I need to stay in hospital?

No. The programme is non-toxic and can be used safely at home under medical supervision.


FAQ - Obtaining the Programme

1. What is the first step?

Complete and submit the CFIDS Questionnaire here:
https://www.cfidshealth.com/questionnaire.html

2. How long for a reply?

Replies are sent within 48-96 hours.

3. How much does it cost?
Costs depend on individual customization. For full details, contact the Petrovic CFIDS Health Center.

4. How long for delivery?

Preparation takes 12-25 business days. Delivery takes 7-9 days by airmail or 2-4 days by courier.


FAQ - General

1. How often should I update progress?

Weekly by email. Guidance is provided throughout the programme free of charge.

2. When was the CFIDS Protocol first used?

The first treatment was in 1994, resulting in complete recovery with no relapse reported over a 16-year follow-up.
FAQ - Support

1. Can my local doctor monitor my progress?

Yes. Local medical supervision is recommended.

If antibiotics are needed, pause the CFIDS Protocol until antibiotics are finished.

2. What if others say CFIDS has no cure?

The CFIDS Protocol supports the body's natural recovery mechanisms. Refer them to documented reports on this website.


FAQ - International

1. Why is Dr Petrovic based in South Africa?

Because his CFIDS research and development began there.

2. Does Dr Petrovic work with international patients?

Yes. Since 1995, patients from the USA, UK, and Australia have participated with positive outcomes.

3. Can I contact other participants?
Yes, with their consent. Contact details are available on the CFIDS Protocol Contacts Worldwide page


FAQ - About CFIDS

1. Is CFIDS contagious?
No, it is not. However, if members of the same social group or family have been exposed to the same negative environmental, biological, or biochemical factors, they may develop CFIDS.

2. Can CFIDS be treated with antibiotics, antidepressants, tranquilizers, immunoglobulins, buprenorphine-HCL, Ampligen, antifungal or homeopathic medicine? Can it be treated with rotational diet or the 'anti-candida' diet? Can fasting improve CFIDS symptoms?

None of these drugs/substances address the underlying cause of CFIDS - systemic oxidative stress. Some may provide temporary symptom relief, but chronic use often carries limitations and potential long-term effects. Rotational diet and elimination of certain dietary products may help with fungal overgrowth, providing temporary improvement in symptoms. Fasting may temporarily reduce free radicals in the bowel and improve symptoms, but it does not neutralize systemic oxidative stress or modulate the immune response permanently.
3. Can various psychological approaches, reverse therapy etc. improve CFIDS symptoms

Although psychological approaches may have temporary beneficial effects on the neuro-vegetative system, they cannot address the root cause of CFIDS because they do not:

A) Replenish crucial micronutrient deficiencies.

B) Provide substantial modulation of the immune response and improvements in neutrophil functional responses (quantitative and qualitative), which are described in antioxidant programs by Dr Boxer, L.A., in "The role of antioxidants in modulating neutrophil functional responses" Adv. Exp Med Biol, 262:19-33,1990.

C) Neutralize systemic oxidative stress as described by Dr Pall (Washington Medical School).

4. Has anybody else confirmed Dr Petrovic's findings?

Prof Dr Terence Kilroe-Smith and other experts have monitored and reviewed Dr Petrovic’s work. Patient reports and scientific findings are documented and available on:
https://www.cfidshealth.com/latest-news-1.html

The Australian National Centre for Digestive Diseases confirmed full clinical reversal of auto- immune Chron's disease in a former Australian National basketball representative (Jason White) who underwent the CFIDS Protocol. Full reversal of Chron's disease has been also confirmed via endoscopic and histological examination / biopsy in two RSA patients. These are unique and exiting medical findings that confirm very powerful immunomodulatory properties of the CFIDS Protocol that can apparently successfully address certain auto- immune entities as well. Clinical reports on these recoveries are available on:
https://www.cfidshealth.com/latest-news-4.html

In the beginning of 1998, Canadian Pilot Study was launched in a group of several selected bedridden CFIDS patients who did not respond to any treatment procedures in the USA and Canada. All patients ( 100%)responded to Dr Petrovic ’s programme, reporting excellent therapeutic responses and recovery from CFIDS.

Many physicians around the world confirmed excellent therapeutic responses and successful recoveries of their local patients who underwent the CFIDS Protocol as well. These doctors include Dr Jackson ( USA), Dr Cordas (USA) Dr McGee (UK ) and other specialist physicians whose medical findings/reports are available on our web sites as well

5. Apart from the extended CDC Atlanta CFIDS criteria, is there any other laboratory way to diagnose CFIDS?

University of Newcastle (Australia) provides 'Bioscreen' tests showing statistical correlation between CFIDS and certain urinary metabolites (CFSUM1, CFSUM2, tyrosine, beta-alanine, acetic acid, succinic acid). Abnormalities in 2-5A synthetase/RNase L and PKR antiviral defense mechanisms have also been reported. These findings support the understanding of immune dysfunction in CFIDS but are not exclusively specific to CFIDS.
6. Have any of Dr Petrovic's patients been tested using the Bioscreen methodology?

Yes, 4 Australian patients showed significant improvement in CFIDS criteria and urinary markers after treatment (1998 research study).


FAQ - Contacts and Communication

1. I would like to speak to Dr Petrovic personally. Alternatively, I would like to send an e-mail to him. Does he charge anything for this type of consultation?

All telephonic consultations are charged as per standard consulting rates and must be arranged minimum 4 weeks in advance. Preliminary e-mail consulting is currently provided free of charge for all patients.

For all enquiries, please email or call:

Emails:
longvita@yebo.co.za
longevitas@gmail.com
cfidscure@yahoo.com
longvita@hotmail.com

Telephone: +27 11 465 6651


Disclaimer:

This website is maintained for historical and reference purposes only.
The Petrovic CFIDS Health Center has permanently closed its physical premises.
All information is presented for educational and research reference, not for clinical use or medical diagnosis.